Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.

  • G. Norman
  • , S. Rice
  • , E. Spackman
  • , L. Stirk
  • , A. Danso-Appiah
  • , D. Suh
  • , S. Palmer
  • , A. Eastwood

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)33-42
Number of pages10
JournalHealth Technology Assessment
Volume15 Suppl 1
DOIs
StatePublished - May 2011

ASJC Scopus Subject Areas

  • Health Policy

Cite this